Delivery Order SPE2DB20D9156-SPE2DB24FH26V
Award Date
10/18/23
Potential Completion Date
11/8/23
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the delivery of Xolair 150 mg/ml syringes with a potential value of seven hundred seventy-three dollars. The order has a firm fixed price and requires completion by June 29, 2023. It utilizes no set-aside designation. DMS Pharmaceutical Group Inc. will deliver the pharmaceutical products to the Defense Logistics Agency location in Park Ridge, Illinois. The Defense Logistics Agency manages the...
The Defense Logistics Agency awarded a $1,547 delivery order to DMS Pharmaceutical Group Inc. to supply Xolair 150 mg/ml syringes for use by the Department of Defense. The firm fixed price order is for product delivery to a location in Park Ridge, Illinois between September 2023 and October 2023. No additional details were provided on the original solicitation or whether this award was issued against an existing government-wide acquisition contract vehicle. DMS Pharmaceutical Group will...
The Defense Logistics Agency (DOD) awarded a $46,422 delivery order to DMS Pharmaceutical Group Inc. for Xolair 150 mg/ml syringes. The firm fixed price order is for product delivery to a location in Park Ridge, Illinois between September 8-29, 2023. DMS Pharmaceutical Group will supply the Defense Logistics Agency with the specified pharmaceutical product to support the agency's medical logistics programs. No set aside designation or subcontractors were identified for this delivery order...
The Defense Logistics Agency (DOD) awarded a $7,737 delivery order to DMS Pharmaceutical Group Inc. for Xolair 150 mg/ml syringes. The firm fixed price order is for product delivery to a location in Park Ridge, Illinois between July 7th and July 28th, 2023. No additional details were provided on the original solicitation or whether this award is associated with a larger governmentwide acquisition contract vehicle. DMS Pharmaceutical Group Inc. will serve as the prime contractor to fulfill the...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $9,284.40 by the Defense Logistics Agency to provide Xolair 150 mg/ml syringes. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was applied to this delivery order. DMS Pharmaceutical...
DMS Pharmaceutical Group Inc. was awarded a $7,737 firm fixed price delivery order against an unspecified government-wide acquisition contract to supply Xolair 150 mg/ml syringes to the Defense Logistics Agency Troop Support Medical. The delivery order has a period of performance through November 13, 2023 and was awarded on October 20, 2023. No set-aside designation was applied to this procurement. DMS Pharmaceutical Group Inc. will fulfill the delivery order from its location in Park Ridge,...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $18,568.80 by the Defense Logistics Agency to provide Xolair 150 mg/ml syringes. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was applied to this delivery order. DMS...
The Defense Logistics Agency awarded a $1,547 delivery order to DMS Pharmaceutical Group Inc. for Xolair 150 mg/ml syringes. This firm fixed price order is being carried out under the prime contractor's existing contract vehicle to supply pharmaceutical products to various Department of Defense components. DMS Pharmaceutical will deliver the specified medication to a customer located in Park Ridge, Illinois, with performance required between September and October 2023. No set aside provisions or...
The Defense Logistics Agency awarded a $773 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for Xolair 150 mg/ml syringes to be delivered by June 1, 2023. No set-aside provisions were applied to this award placed under an unspecified multiple award contract vehicle. DMS Pharmaceutical Group Inc. will provide the Xolair syringes to the Defense Logistics Agency, the agency responsible for worldwide logistics support to the United States...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $22,437.30 by the Defense Logistics Agency to provide Xolair 150 mg/ml syringes. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply various pharmaceutical items and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was applied to this delivery order....